← Leaderboards
Michael Castle
University Of California, San Diego
$1,131,286
Attributed
$2,408,321
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $832.2K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,408,321 · 2
By mechanism
R01$1,971,071 · 1
R21$437,250 · 1
Top collaborators
- Mark H Tuszynski6 shared
- Pengzhe Lu1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Clotilde Lagier-Tourenne$11,959,245
- Mark H Tuszynski$42,403,260
- Wonkyu Ju$7,383,492
- Jae K Lee$8,143,378
- Andrew D Chisholm$11,607,483
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposDoseGene TherapyDependovirusAdeno-Associated Viral VectorDesignSpinal CordRodentNext GenerationCellsNeuronsBehavioralCognitive FunctionAmyloidClinical TreatmentClinical TrialsDisease ModelAntibody ResponseAgingCerebrospinal FluidCellular BiologyCellular TransductionAnatomyBrain Region
Grant awards (6)
Rapid In Vivo Screening of Combination Gene Therapies for Axonal Regeneration after Spinal Cord Injury$437,250
R21 · FY2024 · NS
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,965
R01 · FY2024 · AG
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,401
R01 · FY2023 · AG
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,412
R01 · FY2022 · AG
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$394,032
R01 · FY2021 · AG
Improved Intrathecal BDNF Gene Therapy for Alzheimer's Disease$393,261
R01 · FY2020 · AG